Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer

Journal of Palliative Medicine

Volumn 13, Issue 10, 2010, Pages 1193-1197

  Hardy, Janet Rea ^a   Carmont, Sue Ann S ^b   O'Shea, Angela ^a   Vora, Rohan ^c   Schluter, Philip ^d   Nikles, Catherine Jane ^b   Mitchell, Geoffrey Keith ^b  

^a MATER ADULT HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^d AUCKLAND UNIVERSITY OF TECHNOLOGY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADULT; AGED; ARTICLE; CANCER FATIGUE; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE CALCULATION; DRUG DOSE TITRATION; FEMALE; HUMAN; MALE; PILOT STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM STIMULANTS; FATIGUE; FEMALE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; NEOPLASMS; PILOT PROJECTS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 78049260064     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2010.0185     Document Type: Article

References (16)

1. Piper BF, Dibble SL, Dodd MJ, Weiss MC, Slaughter RE, Paul SM: The revised Piper Fatigue Scale: Psychometric evaluation in women with breast cancer. Oncol Nurs Forum 1998;25:677-684.
2. Vogelzang NJ, Breitbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH, Scherr SL, Portenoy RK: Patient, caregiver, and oncologist perceptions of cancerrelated fatigue: Results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol 1997;34: S (2):4-12.
3. Methylphenidate. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook, 2006. http://amh.hcn. net.au/(Last accessed October 25, 2006).
4. NCCN Cancer-Related Fatigue Panel: Cancer-related fatigue. NCCN Practice Guidelines on Oncology, Volume 1, 2006. Jenkintown, PA: National Comprehensive Cancer Network, 2006.
5. Sarhill N, Walsh D, Nelson KA, Homsi J, Le Grand S, Davis MP: Methylphenidate for fatigue in advanced cancer; A prospective open-label pilot study. Am J Hospice Palliat Med 2001;18:187-192.
6. Breitbart W, Rosenfeld B, Kaim M, Funesti-Esch J: A randomized, double-blind, placebo controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease. Arch Intern Med 2001;161:411-420.
7. Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H: Does methylphenidate reduce the symptom of chronic fatigue syndrome? Am J Med 2006;119:167e.23-.e.30.
8. Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, Palmer JL: Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073-2078.
9. Guyatt GH, Haynes RB, Jaeschke RZ, Cook DJ, Green L, Naylor CD, Wilson MC, Richardson WS: Users' guides to the medical literature: XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA 2000;284:1290-1296.
10. Nikles J, Mitchell G, Walters J, Hardy J, Good P, Rowett D, Shelby-James T, Currow D: Prioritising drugs for singlepatient (n-of-1) trials in palliative care. Palliat Med 2009;23:623-634.
11. Cella D: The Functional Assessment of Cancer Therapy-Anaemia (FACTAn) Scale: A new tool for the assessment of outcomes in cancer anaemia and fatigue. Sem Hematol 1997;34:13-19.
12. Wu H, Wyrwich K, McSweeney M: Assessing fatigue in persons with cancer: Further validation of the Wu Cancer Fatigue Scale. J Pain Symptom Manage 2006;32:255-265.
13. Lloyd Williams M, Friedman T, Rudd N. Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression on patients with advanced metastatic cancer. J Pain Symptom Manage 2000;20:259-265.
14. Farrar JT, Young JPJ, La Moreaux L, Werth JL, Poole RM: Clinical importance of changes in chronic pain intensity measured on an 11 point numerical pain rating scale. Pain 2001;94:149-158.
15. Abernethy AP, Shelby-James T, Fazekas BS, Woods D, Currow DC: Performance status across PC settings: Agreement between three versions of the Karnofsky Performance Scale. BMC Palliat Care 2005;4:7.
16. Zucker DR, Schmid CH, McIntosh MW, D'Agostino RB, Selker HP, Lau J: Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual participant responses to treatment. J Clin Epidemiol 1997;50:401-410.